glp-1 agonist and heart failure Frontiers Glucagon-like peptide-1 receptor agonists' impact

In my latest essay, I share my journey of building a career outside traditional medicine and why, sometimes, the greatest risk is taking no risk at all

For instance, replacing problematic functional groups, such as the carboxylic acid group in danuglipron, with alternative structures has shown promise

Natalia Johnsen, MD Medical Reviewer Natalia Johnsen, MD, is a triple board-certified physician in internal medicine, lifestyle medicine, and obesity medicine, practicing as an internist and consultant at the Vancouve

Timing: Can be taken with or between meals

The experts agreed that the choice between sequential and combined therapy largely depends on patient factors such as cardiovascular risk, stages of chronic kidney disease, comorbidities, body weight, and HbA1c levels